🇺🇸 FDA
Patent

US 7863296

Selective serotonin receptor inverse agonists as therapeutics for disease

granted A61KA61K31/138A61K31/445

Quick answer

US patent 7863296 (Selective serotonin receptor inverse agonists as therapeutics for disease) held by ACADIA Pharmaceuticals Inc. expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADIA Pharmaceuticals Inc.
Grant date
Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/138, A61K31/445, A61K31/4468, A61K45/06